IBDEI20D ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34072,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,34072,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,34073,0)
 ;;=Z80.41^^131^1681^38
 ;;^UTILITY(U,$J,358.3,34073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34073,1,3,0)
 ;;=3^Family Hx of Malig Neop of Ovary
 ;;^UTILITY(U,$J,358.3,34073,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,34073,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,34074,0)
 ;;=Z80.42^^131^1681^39
 ;;^UTILITY(U,$J,358.3,34074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34074,1,3,0)
 ;;=3^Family Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,34074,1,4,0)
 ;;=4^Z80.42
 ;;^UTILITY(U,$J,358.3,34074,2)
 ;;=^5063349
 ;;^UTILITY(U,$J,358.3,34075,0)
 ;;=Z80.43^^131^1681^40
 ;;^UTILITY(U,$J,358.3,34075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34075,1,3,0)
 ;;=3^Family Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,34075,1,4,0)
 ;;=4^Z80.43
 ;;^UTILITY(U,$J,358.3,34075,2)
 ;;=^5063350
 ;;^UTILITY(U,$J,358.3,34076,0)
 ;;=Z80.6^^131^1681^32
 ;;^UTILITY(U,$J,358.3,34076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34076,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,34076,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,34076,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,34077,0)
 ;;=Z80.8^^131^1681^37
 ;;^UTILITY(U,$J,358.3,34077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34077,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,34077,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,34077,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,34078,0)
 ;;=Z81.8^^131^1681^42
 ;;^UTILITY(U,$J,358.3,34078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34078,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,34078,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,34078,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,34079,0)
 ;;=Z82.3^^131^1681^49
 ;;^UTILITY(U,$J,358.3,34079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34079,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,34079,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,34079,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,34080,0)
 ;;=Z82.49^^131^1681^31
 ;;^UTILITY(U,$J,358.3,34080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34080,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,34080,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,34080,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,34081,0)
 ;;=Z82.5^^131^1681^22
 ;;^UTILITY(U,$J,358.3,34081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34081,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,34081,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,34081,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,34082,0)
 ;;=Z82.61^^131^1681^21
 ;;^UTILITY(U,$J,358.3,34082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34082,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,34082,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,34082,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,34083,0)
 ;;=Z82.69^^131^1681^44
 ;;^UTILITY(U,$J,358.3,34083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34083,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,34083,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,34083,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,34084,0)
 ;;=Z83.3^^131^1681^28
 ;;^UTILITY(U,$J,358.3,34084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34084,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,34084,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,34084,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,34085,0)
 ;;=Z83.2^^131^1681^24
 ;;^UTILITY(U,$J,358.3,34085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34085,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
